Bummer.

But...am I crazy?

There seems to still be a glimmer of hope.

They announced firmly along with the top line results that they will continue to develop it.

Seems like there may have been some promising secondary results?

Or other indications identified? Or something?

Still seems odd that the Phase II, admittedly post-hoc results were so good and it still failed.

Guess we'll find out soon.